MA
MUBARAK A. ALAMRI
Prince Sattam Bin Abdulaziz University, University of Birmingham, Massachusetts College of Pharmacy and Health Sciences, King Saud University
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · Synthesis and Characterization of Heterocyclic Compounds · Synthesis and biological activity
0000-0003-0678-593X
About
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia
Employment
Education
- 2015 - 2019
- 2012 - 2014
-
King Saud University Bachelor? - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Structural and Dynamic Characterization of Marine-Derived Metabolites as Inhibitors of L, D-Transpeptidase 2 Enzyme of Mycobacterium Tuberculosis: An Insight From Sequential Computational Workflow Save
- Identification of phyto-immunomodulators of CD8A and PTPRC from Schinus molle as potential therapeutics of chronic chagasic cardiomyopathy via integrative transcriptomics and molecular dynamic simulation approaches Save
- HDAC inhibitors as ferroptosis sensitizers in cancer: Epigenetic regulation of redox balance and iron metabolism Save
- Multi-scale computational analysis of monoacylglycerol lipase inhibition as a new therapeutic strategy for hepatocellular carcinoma Save
- Identification of host immune regulatory targets and their modulators in Leishmania infantum infection through integrated transcriptomic and molecular modeling approaches Save
- Machine learning-guided rational engineering of ACE2-derived peptides for broad-spectrum neutralization of SARS-CoV-2 variants Save
- In-silico identification of potential peptide inhibitors to disrupt NLRP3 inflammasome complex formation by blocking NLRP3-ASC pyrin-pyrin interactions Save
- Association between vitamin D deficiency and depressive symptoms among shift workers: Insights from network pharmacology and bioinformatics studies Save
- Bronchodilator, erectogenic, and aphrodisiac effects of thymol, carvacrol, and their acetate derivatives: In vivo, ex vivo, and in silico insights Save
- Synthesis, molecular modelling, and evaluation of new mono- and bis-isoxazolines as antibacterial agents: in vitro and in silico analysis Save
- Rational design, docking, simulation, synthesis, and in vitro studies of small benzothiazole molecules as selective BACE1 inhibitors Save
- Structure-Based Identification of Natural MTH1 Inhibitors for Breast Cancer Therapy via Molecular Docking and Dynamics Simulations Save
- Inhibition of Activated Coagulation Factor XII by the Phosphodiesterase-4 Inhibitor Roflumilast: In Vitro and In Silico Studies Save
- Exploring marine-derived bioactive compounds for dual inhibition of Pseudomonas aeruginosa LpxA and LpxD: integrated bioinformatics and cheminformatics approaches Save
- Computational assessment of the reactivity and anticancer activity of 1,2,3-triazole-thiazolidinones derivatives: An approach combining DFT calculations, molecular dynamics simulations, molecular docking, and ADMET Save
- Novel and innovative sustainable HNFM@FeCl4 DES as an electrolyte, solvent, and catalyst for rapid electro-organic synthesis of spirooxindole and 4H-pyran derivatives with cytotoxicity assessment Save
- Elucidating the interactions of advanced glycation end products with RAGE, employing molecular docking and MD simulation approaches: Implications of potent therapeutic for diabetes and its related complications Save
- Targeting EGFR by Newer 1-(3,5-Bis((E)-4‑hydroxy-3-methoxystyryl)-1H-pyrazol-1-yl)-2-((substituted phenyl)amino)ethan-1-one Analogues for the Treatment of Cancer: Synthesis, In-vitro and In-silico Studies Save
- Flavonoids as potential KRAS inhibitors: DFT, molecular docking, molecular dynamics simulation and ADMET analyses Save
- Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular Docking, molecular dynamic Simulation, and DFT analyses Save